Trial Profile
A single center,retrospective study assessing outcomes after plerixafor administration for autologous stem cell mobilization
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2017
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Granulocyte colony-stimulating factors
- Indications Myeloma; Stem cell mobilisation
- Focus Therapeutic Use
- 13 Jul 2017 New trial record